Menopause and Hearing Loss: What the Science Actually Shows

Why your lifetime estrogen exposure may matter more than the moment menopause begins.

When women come into my office to talk about perimenopause and menopause, we usually end up covering the familiar list: hot flashes, broken sleep, mood shifts, brain fog, changes in body composition. Hearing almost never comes up. And yet nearly 48 million Americans are living with some degree of hearing loss, and the downstream effects on cognition, social connection, and overall quality of life are significant. So it is fair to ask the obvious question. Does menopause play a role in hearing decline, the way it does in so many other systems?

The honest answer is more nuanced than most people expect, and a recent study published in Annals of Otology, Rhinology & Laryngology gives us a more precise way to think about it.

Why this question matters now

Women today are spending a larger share of life in the postmenopausal years than any generation before them. That makes understanding how hormonal changes influence long term outcomes genuinely important, not just academically interesting. Estrogen is not simply a reproductive hormone. It has measurable effects on vascular health, neural function, and inflammation throughout the body. When it comes to hearing specifically, estrogen influences cochlear blood flow and auditory processing pathways, which creates a plausible biological link between reproductive aging and hearing decline.

But plausibility is not the same as clinical reality, and this is where the data gets interesting.

Menopause itself may not be the driver

One of the more surprising findings from this research is what did not show up. After adjusting for age, health conditions, and noise exposure, simply being postmenopausal was not associated with worse hearing. That matters because we often frame the menopausal transition as a clear turning point for multiple health declines at once. In this case, the presence or absence of menopause alone did not explain the differences in hearing between women.

To me, that suggests we may be asking the wrong question entirely. Instead of asking whether menopause causes hearing loss, it is more useful to ask how long a woman’s body has been exposed to her own endogenous estrogen over time.

Duration of estrogen exposure tells a different story

When the researchers moved past menopausal status and started looking at timing, a different pattern emerged. Women who experienced menopause later in life had better hearing compared to those who went through menopause earlier. A longer reproductive lifespan – defined as the years between menarche and menopause – was similarly associated with better hearing outcomes.

The effect sizes were modest, but they were consistent. On average, longer exposure to endogenous estrogen correlated with slightly better hearing thresholds. That points toward a gradual, cumulative relationship rather than a single hormonal event flipping a switch.

The physiology supports the pattern

There are several mechanisms that make this biologically coherent. Estrogen has antioxidant and anti-inflammatory properties, and it promotes vasodilation, which supports blood flow to the delicate inner ear structures that hearing depends on. At the cellular level, estrogen receptors are present in both the inner ear and the auditory cortex, and there is evidence that estrogen helps protect cochlear hair cells from damage and may reduce neuroinflammation.

Put together, these effects suggest that longer exposure to endogenous estrogen could provide a mild protective influence on the auditory system over time. It fits with what we already understand about estrogen as a broadly protective signaling molecule. But perspective matters here, and this is where I want to slow down.

Hormone replacement therapy is not the answer here

If longer endogenous estrogen exposure looks mildly protective, it is tempting to jump to the conclusion that hormone replacement therapy would improve hearing outcomes. This study did not support that conclusion. Among postmenopausal women, there was no significant association between hormone replacement therapy use and hearing levels.

That is consistent with the broader literature, which has been inconsistent for years. Some studies suggest benefit, others show no effect, and a few even raise concerns about potential harm. One important limitation of this study is that it did not include details about the type, dose, or duration of hormone therapy used. So the absence of a signal is informative, but it does not fully resolve the question.

As a clinician, I think this is worth saying clearly. Hormone therapy has many well established considerations, both potential benefits and risks, that should be discussed in context. Hearing is not one of the outcomes we should be using to make that decision.

What this actually means for real women

The most practical takeaway is not about a new intervention. It is about reframing expectations. Menopause itself does not appear to be a direct driver of hearing loss. Hearing changes over time likely reflect a combination of aging, cumulative exposures, metabolic health, and possibly the duration of endogenous hormone signaling across the lifespan.

That shifts the focus away from any single lever and toward long term trajectory. The contributors to hearing decline that we already know matter still matter most:

• Noise exposure over the lifespan
• Cardiovascular health
• Metabolic factors

Hormones may play a role in the background, but they are one piece of a much larger system.

What this does not mean

It does not mean estrogen is a primary lever for preventing hearing loss. It does not mean hormone therapy should be prescribed with hearing outcomes in mind. And it does not mean the associations observed in this study are clinically significant at the individual level. The differences in hearing thresholds, while statistically meaningful, were relatively small. Not every statistically significant finding translates into a meaningful change in real world function, and I think it is important to hold that line.

A more useful way to think about it

What I appreciate about this study is that it reinforces a broader principle I come back to often in longevity medicine. Timing and exposure often matter more than binary states. Rather than asking whether someone is pre or postmenopausal, it is often more informative to look at how long different physiological systems have been supported or stressed over time.

In this case, longer endogenous estrogen exposure appears modestly associated with better hearing. But the signal is subtle, and the clinical implications remain uncertain. That is not a disappointing conclusion. It is an honest one, and it matches how most of physiology actually works.

The bottom line

Menopause is not the turning point for hearing loss that it is sometimes assumed to be. The more relevant variable appears to be cumulative hormonal exposure across the lifespan, and even then the effect is modest and sits within a much larger context of aging and environmental influences. Hearing health, like most aspects of longevity, is shaped by patterns over time. Understanding those patterns is almost always more useful than looking for a single cause.

Reference: Hsu, J. Z., Gu, K., Nguyen, B., & Choi, J. S. (2026). Association of menopause and hormone replacement therapy with hearing loss. Annals of Otology, Rhinology & Laryngology.